Image for Voyager Clinical Trial

VOYAGER

A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).

Location Description

For more than 90 years, Bergonié Institute has contributed to medical progress and to the international influence of research in the prevention, detection and treatment of cancer, a chronic disease which has become the second leading cause of death in the world.

Bordeaux, France Clinical Trial Location

Institut Bergonié
229 Cours de l’Argonne,
33000 Bordeaux, France